Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Aussie Research Pinpoints Source Of Aggressive Breast Cancer

This article was originally published in PharmAsia News

Executive Summary

Australian researchers report they have traced the most aggressive forms of breast cancer to cells in the lining of mammary ducts, indicating a focus for fighting the disease. The research team at a medical research institute believes the pre-cancerous cells may be behind the cancer, instead of the disease originating in breast stem cells as generally believed. The lead researcher said the finding could lead to new drugs or other treatments for the aggressive form of the breast cancer. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC072650

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel